SG11202101734RA - Dimethyl amino azetidine amides as jak inhibitors - Google Patents
Dimethyl amino azetidine amides as jak inhibitorsInfo
- Publication number
- SG11202101734RA SG11202101734RA SG11202101734RA SG11202101734RA SG11202101734RA SG 11202101734R A SG11202101734R A SG 11202101734RA SG 11202101734R A SG11202101734R A SG 11202101734RA SG 11202101734R A SG11202101734R A SG 11202101734RA SG 11202101734R A SG11202101734R A SG 11202101734RA
- Authority
- SG
- Singapore
- Prior art keywords
- dimethyl amino
- jak inhibitors
- amino azetidine
- amides
- azetidine amides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Transplantation (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862726562P | 2018-09-04 | 2018-09-04 | |
| PCT/US2019/049276 WO2020051105A1 (en) | 2018-09-04 | 2019-09-03 | Dimethyl amino azetidine amides as jak inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202101734RA true SG11202101734RA (en) | 2021-03-30 |
Family
ID=67982186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202101734RA SG11202101734RA (en) | 2018-09-04 | 2019-09-03 | Dimethyl amino azetidine amides as jak inhibitors |
Country Status (27)
| Country | Link |
|---|---|
| US (4) | US10947229B2 (es) |
| EP (1) | EP3837258B1 (es) |
| JP (2) | JP7324836B2 (es) |
| KR (1) | KR20210056381A (es) |
| CN (1) | CN112739697B (es) |
| AR (1) | AR116115A1 (es) |
| AU (1) | AU2019336167B2 (es) |
| BR (1) | BR112021004052A2 (es) |
| CL (1) | CL2021000514A1 (es) |
| CO (1) | CO2021002977A2 (es) |
| DK (1) | DK3837258T3 (es) |
| EA (1) | EA202190681A1 (es) |
| ES (1) | ES2982858T3 (es) |
| FI (1) | FI3837258T3 (es) |
| HR (1) | HRP20241002T1 (es) |
| HU (1) | HUE068058T2 (es) |
| IL (1) | IL281146B2 (es) |
| LT (1) | LT3837258T (es) |
| MA (1) | MA53229A (es) |
| MX (1) | MX2021002521A (es) |
| PH (1) | PH12021550368A1 (es) |
| PL (1) | PL3837258T3 (es) |
| PT (1) | PT3837258T (es) |
| SG (1) | SG11202101734RA (es) |
| SI (1) | SI3837258T1 (es) |
| TW (1) | TWI791886B (es) |
| WO (1) | WO2020051105A1 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3371186A1 (en) | 2015-11-03 | 2018-09-12 | Theravance Biopharma R&D IP, LLC | Jak kinase inhibitor compounds for treatment of respiratory disease |
| EA037748B1 (ru) | 2017-03-09 | 2021-05-18 | ТЕРЕВАНС БАЙОФАРМА Ар энд Ди АйПи, ЭлЭлСи | Конденсированные имидазо-пиперидиновые ингибиторы jak |
| WO2020051105A1 (en) * | 2018-09-04 | 2020-03-12 | Theravance Biopharma R&D Ip, Llc | Dimethyl amino azetidine amides as jak inhibitors |
| BR112021004087A2 (pt) | 2018-09-04 | 2021-05-25 | Theravance Biopharma R&D Ip, Llc | processo para preparar inibidores de jak e seus intermediários |
| JP7383696B2 (ja) | 2018-09-04 | 2023-11-20 | セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー | Ｊａｋ阻害剤としての５員～７員の複素環アミド |
| TW202144343A (zh) * | 2020-03-02 | 2021-12-01 | 美商施萬生物製藥研發 Ip有限責任公司 | Jak抑制劑化合物之結晶水合物 |
| CN115803023A (zh) * | 2020-05-08 | 2023-03-14 | 施万生物制药研发Ip有限责任公司 | 发用奈珠西替尼治疗感染冠状病毒的患者的方法 |
| US20230021647A1 (en) * | 2021-06-21 | 2023-01-26 | Theravance Biopharma R&D Ip, Llc | Method of treating a patient infected with a coronavirus and having a baseline level of crp below 150 mg/l |
| CN117813298A (zh) * | 2021-06-25 | 2024-04-02 | 施万生物制药研发Ip有限责任公司 | 作为jak抑制剂的咪唑吲唑化合物 |
| KR20230092805A (ko) | 2021-12-17 | 2023-06-26 | 주식회사 대웅제약 | (2R, 3S)-2-(3-(4,5-디클로로-1H-벤조[d]이미다졸-1-일)프로필)피페리딘-3-올의 신규한 산부가염 및 결정형 |
| CN119403552A (zh) | 2022-05-05 | 2025-02-07 | 施万生物制药研发Ip有限责任公司 | 用于通过雾化口腔吸入递送的奈珠西替尼 |
| WO2023230236A1 (en) | 2022-05-26 | 2023-11-30 | Theravance Biopharma R&D Ip, Llc | Process for preparing jak inhibitors and intermediates thereof |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI262914B (en) | 1999-07-02 | 2006-10-01 | Agouron Pharma | Compounds and pharmaceutical compositions for inhibiting protein kinases |
| AU2004259012C1 (en) | 2003-07-23 | 2012-08-02 | Exelixis, Inc. | Anaplastic lymphoma kinase modulators and methods of use |
| US20050090529A1 (en) | 2003-07-31 | 2005-04-28 | Pfizer Inc | 3,5 Disubstituted indazole compounds with nitrogen-bearing 5-membered heterocycles, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| US7884109B2 (en) | 2005-04-05 | 2011-02-08 | Wyeth Llc | Purine and imidazopyridine derivatives for immunosuppression |
| US8648069B2 (en) | 2007-06-08 | 2014-02-11 | Abbvie Inc. | 5-substituted indazoles as kinase inhibitors |
| JP2010111624A (ja) | 2008-11-06 | 2010-05-20 | Shionogi & Co Ltd | Ｔｔｋ阻害作用を有するインダゾール誘導体 |
| US20120029190A1 (en) | 2009-04-03 | 2012-02-02 | Douglas Burdi | Compounds for treating disorders mediated by metabotropic glutamate receptor 5, and methods of use thereof |
| EP3305073B1 (en) | 2009-12-21 | 2019-05-15 | Samumed, LLC | 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| US8575336B2 (en) * | 2011-07-27 | 2013-11-05 | Pfizer Limited | Indazoles |
| HUE054560T2 (hu) | 2013-12-05 | 2021-09-28 | Pfizer | Pirrolo[2,3-d]pirimidinil, pirrolo[2,3-b]pirazinil és pirrolo[2,3-d]piridinil akrilamidok |
| EP3143021B1 (en) | 2014-05-14 | 2019-06-12 | Pfizer Inc | Pyrazolopyridines and pyrazolopyrimidines |
| WO2016026078A1 (en) | 2014-08-19 | 2016-02-25 | Changzhou Jiekai Pharmatech Co., Ltd. | Heterocyclic compounds as erk inhibitors |
| KR101663277B1 (ko) | 2015-03-30 | 2016-10-06 | 주식회사 녹십자 | TNIK, IKKε 및 TBK1 억제제로서의 피라졸계 유도체 및 이를 포함하는 약학적 조성물 |
| EP3371186A1 (en) | 2015-11-03 | 2018-09-12 | Theravance Biopharma R&D IP, LLC | Jak kinase inhibitor compounds for treatment of respiratory disease |
| ES2864035T3 (es) | 2015-11-03 | 2021-10-13 | Topivert Pharma Ltd | Derivados de 4,5,6,7-tetrahidro-1h-imidazo[4,5-c]piridina y 1,4,5,6,7,8-hexahidroimidazo[4,5-d]azepina como inhibidores de la quinasa janus |
| DK3371185T3 (da) | 2015-11-03 | 2020-11-30 | Topivert Pharma Ltd | 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pyridin og 1,4,5,6,7,8-hexahydroimidazo[4,5-d]azepinderivater som janus-kinase-inhibitorer |
| US20180258546A1 (en) | 2017-03-09 | 2018-09-13 | Lam Research Corporation | Electroplating apparatus and methods utilizing independent control of impinging electrolyte |
| EA037748B1 (ru) | 2017-03-09 | 2021-05-18 | ТЕРЕВАНС БАЙОФАРМА Ар энд Ди АйПи, ЭлЭлСи | Конденсированные имидазо-пиперидиновые ингибиторы jak |
| AR111495A1 (es) | 2017-05-01 | 2019-07-17 | Theravance Biopharma R&D Ip Llc | Compuestos de imidazo-piperidina fusionada como inhibidores de jak |
| AU2018261591B2 (en) | 2017-05-01 | 2021-09-02 | Theravance Biopharma R&D Ip, Llc | Crystalline forms of a JAK inhibitor compound |
| US10406148B2 (en) | 2017-05-01 | 2019-09-10 | Theravance Biopharma R&D Ip, Llc | Methods of treatment using a JAK inhibitor compound |
| WO2020051105A1 (en) * | 2018-09-04 | 2020-03-12 | Theravance Biopharma R&D Ip, Llc | Dimethyl amino azetidine amides as jak inhibitors |
| BR112021004087A2 (pt) | 2018-09-04 | 2021-05-25 | Theravance Biopharma R&D Ip, Llc | processo para preparar inibidores de jak e seus intermediários |
| JP7383696B2 (ja) | 2018-09-04 | 2023-11-20 | セラヴァンス バイオファーマ アール＆ディー アイピー， エルエルシー | Ｊａｋ阻害剤としての５員～７員の複素環アミド |
| EP3853229A1 (en) | 2018-10-29 | 2021-07-28 | Theravance Biopharma R&D IP, LLC | 2-azabicyclo hexane compound as jak inhibitor |
| FI3932919T3 (fi) | 2019-02-25 | 2024-08-30 | Henan Medinno Pharmaceutical Tech Co Ltd | Jak-inhibiittoriyhdiste ja sen käyttö |
| EA202192426A1 (ru) | 2019-03-05 | 2021-11-15 | Инсайт Корпорейшн | Ингибиторы путей jak1 для лечения хронической дисфункции аллотрансплантата легких |
| CN112279848A (zh) | 2019-07-25 | 2021-01-29 | 四川海思科制药有限公司 | 一种泛JAKs抑制剂及其用途 |
| TW202144343A (zh) * | 2020-03-02 | 2021-12-01 | 美商施萬生物製藥研發 Ip有限責任公司 | Jak抑制劑化合物之結晶水合物 |
| CN115803023A (zh) * | 2020-05-08 | 2023-03-14 | 施万生物制药研发Ip有限责任公司 | 发用奈珠西替尼治疗感染冠状病毒的患者的方法 |
| US20230021647A1 (en) * | 2021-06-21 | 2023-01-26 | Theravance Biopharma R&D Ip, Llc | Method of treating a patient infected with a coronavirus and having a baseline level of crp below 150 mg/l |
-
2019
- 2019-09-03 WO PCT/US2019/049276 patent/WO2020051105A1/en active Application Filing
- 2019-09-03 SG SG11202101734RA patent/SG11202101734RA/en unknown
- 2019-09-03 AU AU2019336167A patent/AU2019336167B2/en active Active
- 2019-09-03 MA MA053229A patent/MA53229A/fr unknown
- 2019-09-03 AR ARP190102520A patent/AR116115A1/es not_active Application Discontinuation
- 2019-09-03 MX MX2021002521A patent/MX2021002521A/es unknown
- 2019-09-03 EA EA202190681A patent/EA202190681A1/ru unknown
- 2019-09-03 EP EP19769674.3A patent/EP3837258B1/en active Active
- 2019-09-03 US US16/559,077 patent/US10947229B2/en active Active
- 2019-09-03 LT LTEPPCT/US2019/049276T patent/LT3837258T/lt unknown
- 2019-09-03 IL IL281146A patent/IL281146B2/en unknown
- 2019-09-03 BR BR112021004052-8A patent/BR112021004052A2/pt unknown
- 2019-09-03 CN CN201980057577.7A patent/CN112739697B/zh active Active
- 2019-09-03 PH PH1/2021/550368A patent/PH12021550368A1/en unknown
- 2019-09-03 PL PL19769674.3T patent/PL3837258T3/pl unknown
- 2019-09-03 KR KR1020217009936A patent/KR20210056381A/ko active Pending
- 2019-09-03 JP JP2021512257A patent/JP7324836B2/ja active Active
- 2019-09-03 FI FIEP19769674.3T patent/FI3837258T3/fi active
- 2019-09-03 HR HRP20241002TT patent/HRP20241002T1/hr unknown
- 2019-09-03 SI SI201930791T patent/SI3837258T1/sl unknown
- 2019-09-03 PT PT197696743T patent/PT3837258T/pt unknown
- 2019-09-03 TW TW108131679A patent/TWI791886B/zh active
- 2019-09-03 DK DK19769674.3T patent/DK3837258T3/da active
- 2019-09-03 HU HUE19769674A patent/HUE068058T2/hu unknown
- 2019-09-03 ES ES19769674T patent/ES2982858T3/es active Active
-
2021
- 2021-02-04 US US17/248,717 patent/US11634419B2/en active Active
- 2021-03-02 CL CL2021000514A patent/CL2021000514A1/es unknown
- 2021-03-04 CO CONC2021/0002977A patent/CO2021002977A2/es unknown
-
2022
- 2022-09-06 JP JP2022141182A patent/JP2022172299A/ja active Pending
-
2023
- 2023-03-09 US US18/181,138 patent/US20230322774A1/en not_active Abandoned
-
2024
- 2024-05-31 US US18/680,940 patent/US20250034131A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL281146A (en) | Dimethyl amino aztidine amides as JAK inhibitors | |
| IL268625A (en) | Amino pyrimidine compounds used as SSAO inhibitors | |
| IL282460A (en) | The compound 2-azabicyclohexane as a JAK inhibitor | |
| GB201915593D0 (en) | Hand-held integral aribrush | |
| IL287876A (en) | Jak inhibitors | |
| CA193496S (en) | Screwdriver | |
| IL275374A (en) | Pyrrolidine amides I are converted | |
| IL289266A (en) | new molecules | |
| CA192878S (en) | Brush stand | |
| IL291611A (en) | Jak inhibitors | |
| EP3873473A4 (en) | Aminoazine amides | |
| IL289773A (en) | Disubstituted amino triazoles are useful as chitinase inhibitors | |
| GB2601449B (en) | Key-compressible encryption | |
| GB201708390D0 (en) | Novel alpha-amino amide derivatives | |
| GB201818629D0 (en) | Compositions comprising amino acids | |
| IL290381A (en) | Jak inhibitors | |
| CA190942S (en) | Screw head | |
| LT3735823T (lt) | Lapų šalintuvo galvutė | |
| ZA202201899B (en) | Substituted amino triazoles useful as chitinase inhibitors | |
| GB201903622D0 (en) | Nail brush | |
| GB201913320D0 (en) | Novel proteins | |
| GB201908044D0 (en) | Dopamine-B-Hydroxylase inhibitors | |
| GB201919193D0 (en) | Novel molecules | |
| GB201905476D0 (en) | MAPA4K4 Inhibitors | |
| GB201904756D0 (en) | Novel proteins |